chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chest discomfort, Headache, Malaise, Myalgia
Clinical narrative: Body aches,muscle pain,hurting all over; Headache; Soreness at injection site; Stomach pain; Pressure on the chest; felt sick; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pain), CHEST DISCOMFORT (Pressure on the chest), MALAISE (felt sick), MYALGIA (Body aches,muscle pain,hurting all over) and HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stomach pain and Chest pressure.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain), CHEST DISCOMFORT (Pressure on the chest), MALAISE (felt sick) and VACCINATION SITE PAIN (Soreness at injection site). On 09-Apr-2021, the patient experienced MYALGIA (Body aches,muscle pain,hurting all over) and HEADACHE (Headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ALKA SELTZER [ACETYLSALICYLIC ACID]) at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (Stomach pain), CHEST DISCOMFORT (Pressure on the chest), MALAISE (felt sick), MYALGIA (Body aches,muscle pain,hurting all over), HEADACHE (Headache) and VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medication was not reported by the reporter but it is reported that patient is taking other medication, not specified. The patient did not throw up, have nausea, vomiting or fever. She never had the flu. She wanted to know should she take the second shot.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Body aches,muscle pain,hurting all over; Headache; Soreness at injection site; Stomach pain; Pressure on the chest; felt sick; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pain), CHEST DISCOMFORT (Pressure on the chest), MALAISE (felt sick), MYALGIA (Body aches,muscle pain,hurting all over) and HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stomach pain and Chest pressure.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain), CHEST DISCOMFORT (Pressure on the chest), MALAISE (felt sick) and VACCINATION SITE PAIN (Soreness at injection site). On 09-Apr-2021, the patient experienced MYALGIA (Body aches,muscle pain,hurting all over) and HEADACHE (Headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ALKA SELTZER [ACETYLSALICYLIC ACID]) at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (Stomach pain), CHEST DISCOMFORT (Pressure on the chest), MALAISE (felt sick), MYALGIA (Body aches,muscle pain,hurting all over), HEADACHE (Headache) and VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medication was not reported by the reporter but it is reported that patient is taking other medication, not specified. The patient did not throw up, have nausea, vomiting or fever. She never had the flu. She wanted to know should she take the second shot.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: llarge rash at the injection site; had bulk site; itchy at the injection site; lot of fatigue; nausea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE RASH (llarge rash at the injection site), VACCINATION SITE SWELLING (had bulk site), VACCINATION SITE PRURITUS (itchy at the injection site), FATIGUE (lot of fatigue) and NAUSEA (nausea) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Osteoporosis (severe osteoporosis) and Alpha thalassemia intermedia. Concomitant products included VITAMIN D3 and VITAMIN K2 [MENAQUINONE] for an unknown indication.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE RASH (llarge rash at the injection site), VACCINATION SITE SWELLING (had bulk site), VACCINATION SITE PRURITUS (itchy at the injection site), FATIGUE (lot of fatigue) and NAUSEA (nausea). At the time of the report, VACCINATION SITE RASH (llarge rash at the injection site), VACCINATION SITE SWELLING (had bulk site), VACCINATION SITE PRURITUS (itchy at the injection site), FATIGUE (lot of fatigue) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication were reported   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow-up received on 04-may-2021:Patient's height , weight , race and ethnic group was updated and concomitant medications were updated
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dysphagia, Lethargy, Pain, Pruritus
Clinical narrative: my arm swelled up; flaming hives around rectal area; thirsty; could'nt swallow; tongue was swelling up; a hive showed up between my middle and index finger and on my palm which was itchy and sore; lethargic; no stamina; fever of 100.7; general body aches; rash; pruritus; This spontaneous case was reported by a health care professional and describes the occurrence of PRURITUS (pruritus), VACCINATION SITE SWELLING (my arm swelled up), PYREXIA (fever of 100.7), PAIN (general body aches) and LETHARGY (lethargic) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fever. Concurrent medical conditions included Allergy (Allergic to Sulphur medications) and Angioedema.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On 05-Apr-2021, the patient experienced PRURITUS (pruritus), PYREXIA (fever of 100.7), PAIN (general body aches) and RASH (rash). On 07-Apr-2021, the patient experienced LETHARGY (lethargic) and ASTHENIA (no stamina). On 08-Apr-2021, the patient experienced URTICARIA (a hive showed up between my middle and index finger and on my palm which was itchy and sore). On 09-Apr-2021, the patient experienced URTICARIA (flaming hives around rectal area), THIRST (thirsty), DYSPHAGIA (could'nt swallow) and SWOLLEN TONGUE (tongue was swelling up). On an unknown date, the patient experienced VACCINATION SITE SWELLING (my arm swelled up). The patient was treated with IBUPROFEN at an unspecified dose and frequency; LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency; METHYLPREDNISOLONE SODIUM SUCCINATE (SOLUMEDROL) at an unspecified dose and frequency; FAMOTIDINE at an unspecified dose and frequency and LEVOTHYROXINE SODIUM (THYROXINE) at an unspecified dose and frequency. On 06-Apr-2021, PYREXIA (fever of 100.7) had resolved. On 07-Apr-2021, PAIN (general body aches) had resolved. On 08-Apr-2021, LETHARGY (lethargic) and ASTHENIA (no stamina) had resolved. On 09-Apr-2021, URTICARIA (a hive showed up between my middle and index finger and on my palm which was itchy and sore), URTICARIA (flaming hives around rectal area), THIRST (thirsty), DYSPHAGIA (could'nt swallow) and SWOLLEN TONGUE (tongue was swelling up) had resolved. At the time of the report, PRURITUS (pruritus), VACCINATION SITE SWELLING (my arm swelled up) and RASH (rash) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter has also mentioned the following events: felt like poker was on my hand; feels like it is in my lymps, like an infection and totally wiped out and puffy,itchy and warm arm.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Swollen tongue, Thirst, Urticaria
Clinical narrative: my arm swelled up; flaming hives around rectal area; thirsty; could'nt swallow; tongue was swelling up; a hive showed up between my middle and index finger and on my palm which was itchy and sore; lethargic; no stamina; fever of 100.7; general body aches; rash; pruritus; This spontaneous case was reported by a health care professional and describes the occurrence of PRURITUS (pruritus), VACCINATION SITE SWELLING (my arm swelled up), PYREXIA (fever of 100.7), PAIN (general body aches) and LETHARGY (lethargic) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fever. Concurrent medical conditions included Allergy (Allergic to Sulphur medications) and Angioedema.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On 05-Apr-2021, the patient experienced PRURITUS (pruritus), PYREXIA (fever of 100.7), PAIN (general body aches) and RASH (rash). On 07-Apr-2021, the patient experienced LETHARGY (lethargic) and ASTHENIA (no stamina). On 08-Apr-2021, the patient experienced URTICARIA (a hive showed up between my middle and index finger and on my palm which was itchy and sore). On 09-Apr-2021, the patient experienced URTICARIA (flaming hives around rectal area), THIRST (thirsty), DYSPHAGIA (could'nt swallow) and SWOLLEN TONGUE (tongue was swelling up). On an unknown date, the patient experienced VACCINATION SITE SWELLING (my arm swelled up). The patient was treated with IBUPROFEN at an unspecified dose and frequency; LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency; METHYLPREDNISOLONE SODIUM SUCCINATE (SOLUMEDROL) at an unspecified dose and frequency; FAMOTIDINE at an unspecified dose and frequency and LEVOTHYROXINE SODIUM (THYROXINE) at an unspecified dose and frequency. On 06-Apr-2021, PYREXIA (fever of 100.7) had resolved. On 07-Apr-2021, PAIN (general body aches) had resolved. On 08-Apr-2021, LETHARGY (lethargic) and ASTHENIA (no stamina) had resolved. On 09-Apr-2021, URTICARIA (a hive showed up between my middle and index finger and on my palm which was itchy and sore), URTICARIA (flaming hives around rectal area), THIRST (thirsty), DYSPHAGIA (could'nt swallow) and SWOLLEN TONGUE (tongue was swelling up) had resolved. At the time of the report, PRURITUS (pruritus), VACCINATION SITE SWELLING (my arm swelled up) and RASH (rash) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter has also mentioned the following events: felt like poker was on my hand; feels like it is in my lymps, like an infection and totally wiped out and puffy,itchy and warm arm.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: my arm swelled up; flaming hives around rectal area; thirsty; could'nt swallow; tongue was swelling up; a hive showed up between my middle and index finger and on my palm which was itchy and sore; lethargic; no stamina; fever of 100.7; general body aches; rash; pruritus; This spontaneous case was reported by a health care professional and describes the occurrence of PRURITUS (pruritus), VACCINATION SITE SWELLING (my arm swelled up), PYREXIA (fever of 100.7), PAIN (general body aches) and LETHARGY (lethargic) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fever. Concurrent medical conditions included Allergy (Allergic to Sulphur medications) and Angioedema.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On 05-Apr-2021, the patient experienced PRURITUS (pruritus), PYREXIA (fever of 100.7), PAIN (general body aches) and RASH (rash). On 07-Apr-2021, the patient experienced LETHARGY (lethargic) and ASTHENIA (no stamina). On 08-Apr-2021, the patient experienced URTICARIA (a hive showed up between my middle and index finger and on my palm which was itchy and sore). On 09-Apr-2021, the patient experienced URTICARIA (flaming hives around rectal area), THIRST (thirsty), DYSPHAGIA (could'nt swallow) and SWOLLEN TONGUE (tongue was swelling up). On an unknown date, the patient experienced VACCINATION SITE SWELLING (my arm swelled up). The patient was treated with IBUPROFEN at an unspecified dose and frequency; LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency; METHYLPREDNISOLONE SODIUM SUCCINATE (SOLUMEDROL) at an unspecified dose and frequency; FAMOTIDINE at an unspecified dose and frequency and LEVOTHYROXINE SODIUM (THYROXINE) at an unspecified dose and frequency. On 06-Apr-2021, PYREXIA (fever of 100.7) had resolved. On 07-Apr-2021, PAIN (general body aches) had resolved. On 08-Apr-2021, LETHARGY (lethargic) and ASTHENIA (no stamina) had resolved. On 09-Apr-2021, URTICARIA (a hive showed up between my middle and index finger and on my palm which was itchy and sore), URTICARIA (flaming hives around rectal area), THIRST (thirsty), DYSPHAGIA (could'nt swallow) and SWOLLEN TONGUE (tongue was swelling up) had resolved. At the time of the report, PRURITUS (pruritus), VACCINATION SITE SWELLING (my arm swelled up) and RASH (rash) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter has also mentioned the following events: felt like poker was on my hand; feels like it is in my lymps, like an infection and totally wiped out and puffy,itchy and warm arm.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 years old patient recieved vaccine; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old patient recieved vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 027L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old patient recieved vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old patient recieved vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details were provided. No treatment information was mentioned.  Company Comment: Based on current available information about patient age and lack of adverse events for the only event of Product administered to patient of inappropriate age the causality is Not applicable event and case are Non-serious.   Most recent FOLLOW-UP information incorporated above includes: On 13-Aug-2021: FU received on 13-Aug-2021 and added second dose vaccination details.; Sender's Comments: Based on current available information about patient age and lack of adverse events for the only event of Product administered to patient of inappropriate age the causality is Not applicable event and case are Non-serious.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Diarrhoea, Headache, Hyperhidrosis, Product dose omission issue
Clinical narrative: deliberately missed her second dose which was slated for yesterday 12Apr2021; vomiting; fever; severe headache; chest pain; sweating; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), HYPERHIDROSIS (sweating), DIARRHOEA (diarrhea), PRODUCT DOSE OMISSION ISSUE (deliberately missed her second dose which was slated for yesterday 12Apr2021) and VOMITING (vomiting) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M02A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pulmonary embolism. Concurrent medical conditions included Immunosuppression (immunosuppressed (low IgG)). Concomitant products included GAMMA GLOBULIN, PANTOPRAZOLE SODIUM SESQUIHYDRATE (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]) and PROPRANOLOL HYDROCHLORIDE (INDERAL) for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced CHEST PAIN (chest pain), HYPERHIDROSIS (sweating), DIARRHOEA (diarrhea), VOMITING (vomiting), PYREXIA (fever) and HEADACHE (severe headache). On 12-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (deliberately missed her second dose which was slated for yesterday 12Apr2021). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) ongoing since an unknown date at an unspecified dose and frequency; PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. On 19-Mar-2021, CHEST PAIN (chest pain), HYPERHIDROSIS (sweating), DIARRHOEA (diarrhea), VOMITING (vomiting), PYREXIA (fever) and HEADACHE (severe headache) had resolved. On 12-Apr-2021, PRODUCT DOSE OMISSION ISSUE (deliberately missed her second dose which was slated for yesterday 12Apr2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Client has a history of pulmonary embolism and is immunosuppress (low IgG) that requires occasional gamma globulin therapy. She took first shot of Moderna COVID-19 vaccine on 15Mar2021 and about 12 hour later, she developed vomiting, diarrhea, fever, sweating, severe headache, chest pain which made her to rush to the emergency room for a visit that lasted about 6 hours with no clear diagnosis made. Symptoms lasted for about 4 days then gradually resolved. She is aware that AE from second shot is worse than first shot and wanted more information to encourage her take the second dose given these severe adverse effects that she had after the first dose of the Moderna. She deliberately missed her second dose which was slated for yesterday 12Apr2021.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: deliberately missed her second dose which was slated for yesterday 12Apr2021; vomiting; fever; severe headache; chest pain; sweating; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), HYPERHIDROSIS (sweating), DIARRHOEA (diarrhea), PRODUCT DOSE OMISSION ISSUE (deliberately missed her second dose which was slated for yesterday 12Apr2021) and VOMITING (vomiting) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M02A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pulmonary embolism. Concurrent medical conditions included Immunosuppression (immunosuppressed (low IgG)). Concomitant products included GAMMA GLOBULIN, PANTOPRAZOLE SODIUM SESQUIHYDRATE (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]) and PROPRANOLOL HYDROCHLORIDE (INDERAL) for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced CHEST PAIN (chest pain), HYPERHIDROSIS (sweating), DIARRHOEA (diarrhea), VOMITING (vomiting), PYREXIA (fever) and HEADACHE (severe headache). On 12-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (deliberately missed her second dose which was slated for yesterday 12Apr2021). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) ongoing since an unknown date at an unspecified dose and frequency; PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. On 19-Mar-2021, CHEST PAIN (chest pain), HYPERHIDROSIS (sweating), DIARRHOEA (diarrhea), VOMITING (vomiting), PYREXIA (fever) and HEADACHE (severe headache) had resolved. On 12-Apr-2021, PRODUCT DOSE OMISSION ISSUE (deliberately missed her second dose which was slated for yesterday 12Apr2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Client has a history of pulmonary embolism and is immunosuppress (low IgG) that requires occasional gamma globulin therapy. She took first shot of Moderna COVID-19 vaccine on 15Mar2021 and about 12 hour later, she developed vomiting, diarrhea, fever, sweating, severe headache, chest pain which made her to rush to the emergency room for a visit that lasted about 6 hours with no clear diagnosis made. Symptoms lasted for about 4 days then gradually resolved. She is aware that AE from second shot is worse than first shot and wanted more information to encourage her take the second dose given these severe adverse effects that she had after the first dose of the Moderna. She deliberately missed her second dose which was slated for yesterday 12Apr2021.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: fever; tiredness; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), FATIGUE (tiredness) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), FATIGUE (tiredness) and HEADACHE (headache). At the time of the report, PYREXIA (fever), FATIGUE (tiredness) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided Treatment information was not provided   This case was linked to MOD-2021-075097 (Patient Link).   Reporter did not allow further contact
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Discomfort, Fatigue, Headache, Myalgia
Clinical narrative: Headache; Chills; Muscle ache; Fever; Vomiting; Fatigue, feeling uncomfortable; feeling fairly uncomfortable; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills), MYALGIA (Muscle ache), PYREXIA (Fever) and VOMITING (Vomiting) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 11-Apr-2021, the patient experienced HEADACHE (Headache), CHILLS (Chills), MYALGIA (Muscle ache), PYREXIA (Fever), VOMITING (Vomiting), FATIGUE (Fatigue, feeling uncomfortable) and DISCOMFORT (feeling fairly uncomfortable). At the time of the report, HEADACHE (Headache), CHILLS (Chills), MYALGIA (Muscle ache), PYREXIA (Fever), VOMITING (Vomiting), FATIGUE (Fatigue, feeling uncomfortable) and DISCOMFORT (feeling fairly uncomfortable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medications are provided. treatment to the events not provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Headache; Chills; Muscle ache; Fever; Vomiting; Fatigue, feeling uncomfortable; feeling fairly uncomfortable; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills), MYALGIA (Muscle ache), PYREXIA (Fever) and VOMITING (Vomiting) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 11-Apr-2021, the patient experienced HEADACHE (Headache), CHILLS (Chills), MYALGIA (Muscle ache), PYREXIA (Fever), VOMITING (Vomiting), FATIGUE (Fatigue, feeling uncomfortable) and DISCOMFORT (feeling fairly uncomfortable). At the time of the report, HEADACHE (Headache), CHILLS (Chills), MYALGIA (Muscle ache), PYREXIA (Fever), VOMITING (Vomiting), FATIGUE (Fatigue, feeling uncomfortable) and DISCOMFORT (feeling fairly uncomfortable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medications are provided. treatment to the events not provided.
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: Pain in the  arm; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the  arm) and MYALGIA (Body aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in the  arm) and MYALGIA (Body aches). At the time of the report, PAIN IN EXTREMITY (Pain in the  arm) and MYALGIA (Body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter called about own symptoms but mentioned that reporter family also had soft side effects like pain in the arm and body aches  No concomitant medication were reported.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-074984, US-MODERNATX, INC.-MOD-2021-075688 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074984:Wife case US-MODERNATX, INC.-MOD-2021-075688:Son case
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: chills; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of CHILLS (chills), the second episode of CHILLS (chills) and PYREXIA (fever) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Blood pressure high.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced the first episode of CHILLS (chills). On 13-Apr-2021, the patient experienced the second episode of CHILLS (chills) and PYREXIA (fever). At the time of the report, last episode of CHILLS (chills) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient reported taking concomitant medications for diabetes and high blood pressure.  Treatment of events was reported as none.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.     On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 07-Sep-2020 and the estimated date of delivery was 14-Jul-2021. On 14-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-first week of the pregnancy.  On 14-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Oct-2020, Pregnancy test: positive positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were reported. No treatment medication details was reported. Estimated date of conception was reported as 19-Sep-2020.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Arthralgia, Asthenia, Chills, Dizziness
Clinical narrative: Sweating; feeling weak; very dizzy; don't even have taste when I eat; whole body was hurting; muscles were hurting; Fever; chills; Headache; redness at my injection site; my shoulder hurts too; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), ASTHENIA (feeling weak), DIZZINESS (very dizzy), AGEUSIA (don't even have taste when I eat) and PAIN (whole body was hurting) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating), ASTHENIA (feeling weak), DIZZINESS (very dizzy), AGEUSIA (don't even have taste when I eat), PAIN (whole body was hurting), MYALGIA (muscles were hurting), PYREXIA (Fever), CHILLS (chills), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (redness at my injection site) and ARTHRALGIA (my shoulder hurts too). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Sweating), ASTHENIA (feeling weak), DIZZINESS (very dizzy), AGEUSIA (don't even have taste when I eat), PAIN (whole body was hurting), MYALGIA (muscles were hurting), PYREXIA (Fever), CHILLS (chills), VACCINATION SITE ERYTHEMA (redness at my injection site) and ARTHRALGIA (my shoulder hurts too) outcome was unknown and HEADACHE (Headache) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable. No concomitant medication information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Myalgia, Pain, Pyrexia
Clinical narrative: Sweating; feeling weak; very dizzy; don't even have taste when I eat; whole body was hurting; muscles were hurting; Fever; chills; Headache; redness at my injection site; my shoulder hurts too; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), ASTHENIA (feeling weak), DIZZINESS (very dizzy), AGEUSIA (don't even have taste when I eat) and PAIN (whole body was hurting) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating), ASTHENIA (feeling weak), DIZZINESS (very dizzy), AGEUSIA (don't even have taste when I eat), PAIN (whole body was hurting), MYALGIA (muscles were hurting), PYREXIA (Fever), CHILLS (chills), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (redness at my injection site) and ARTHRALGIA (my shoulder hurts too). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Sweating), ASTHENIA (feeling weak), DIZZINESS (very dizzy), AGEUSIA (don't even have taste when I eat), PAIN (whole body was hurting), MYALGIA (muscles were hurting), PYREXIA (Fever), CHILLS (chills), VACCINATION SITE ERYTHEMA (redness at my injection site) and ARTHRALGIA (my shoulder hurts too) outcome was unknown and HEADACHE (Headache) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable. No concomitant medication information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Sweating; feeling weak; very dizzy; don't even have taste when I eat; whole body was hurting; muscles were hurting; Fever; chills; Headache; redness at my injection site; my shoulder hurts too; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), ASTHENIA (feeling weak), DIZZINESS (very dizzy), AGEUSIA (don't even have taste when I eat) and PAIN (whole body was hurting) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating), ASTHENIA (feeling weak), DIZZINESS (very dizzy), AGEUSIA (don't even have taste when I eat), PAIN (whole body was hurting), MYALGIA (muscles were hurting), PYREXIA (Fever), CHILLS (chills), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (redness at my injection site) and ARTHRALGIA (my shoulder hurts too). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Sweating), ASTHENIA (feeling weak), DIZZINESS (very dizzy), AGEUSIA (don't even have taste when I eat), PAIN (whole body was hurting), MYALGIA (muscles were hurting), PYREXIA (Fever), CHILLS (chills), VACCINATION SITE ERYTHEMA (redness at my injection site) and ARTHRALGIA (my shoulder hurts too) outcome was unknown and HEADACHE (Headache) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable. No concomitant medication information was provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Extra dose administered, Product storage error, SARS-CoV-2 test
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (the vials were possibly bad, she got a compromised dose), EXTRA DOSE ADMINISTERED (Received 3 rd vaccine) and PRODUCT STORAGE ERROR (improper vaccine storage) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A., 001B21A and 005021A) for COVID-19 vaccination.     Concomitant products included LEVOSULPIRIDE (LEVOGASTROL) from 01-Jan-2014 to an unknown date and VITAMINS NOS for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-May-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (the vials were possibly bad, she got a compromised dose). 09-Apr-2021, the patient experienced PRODUCT STORAGE ERROR (improper vaccine storage). On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (Received 3 rd vaccine). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, EXPIRED PRODUCT ADMINISTERED (the vials were possibly bad, she got a compromised dose) had resolved and EXTRA DOSE ADMINISTERED (Received 3 rd vaccine) and PRODUCT STORAGE ERROR (improper vaccine storage) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Apr-2021, SARS-CoV-2 test: positive (Positive) positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-076202 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: AE contact details were updated.New events were updated, lab details updated On 10-May-2021: Additional event and updated indication added.; Sender's Comments:  MOD-2021-076202:First dose of vaccine case.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Fatigue, Nausea, Vomiting
Clinical narrative: Shortness of breath; Fatigue; Vomiting; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), FATIGUE (Fatigue), VOMITING (Vomiting), CHILLS (Chills) and NAUSEA (Nausea) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced DYSPNOEA (Shortness of breath), FATIGUE (Fatigue), VOMITING (Vomiting), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, DYSPNOEA (Shortness of breath), FATIGUE (Fatigue), VOMITING (Vomiting), CHILLS (Chills) and NAUSEA (Nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided.  The patient did not take any treatment.29 year old male patient called to report that he received moderna vaccine on his left arm on 13mar2021 and experienced fatigue, vomiting, chills, nausea and shortness of breath. No treatment taken and symptoms have resolved
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Feeding disorder, Feeling hot, Headache, Influenza
Clinical narrative: Not taking the 2nd dose; Itchy after the 1st dose; Ringing in ears after 1st dose; Felt like had the worst flu ever had after 1st dose; Arm swollen after 1st dose; Arm hot after 1st dose; Feet hurt after 1st dose/ Arm felt like bees biting after the 1st dose; Neck stiff after 1st dose; Couldn't eat after 1st dose; Nauseous after 1st dose; Temperature of 101.4 F after 1st dose; Exploding headache after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Not taking the 2nd dose), PRURITUS (Itchy after the 1st dose), TINNITUS (Ringing in ears after 1st dose), INFLUENZA (Felt like had the worst flu ever had after 1st dose) and PERIPHERAL SWELLING (Arm swollen after 1st dose) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in August 2020, Nausea and Diarrhea.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Not taking the 2nd dose), PRURITUS (Itchy after the 1st dose), TINNITUS (Ringing in ears after 1st dose), INFLUENZA (Felt like had the worst flu ever had after 1st dose), PERIPHERAL SWELLING (Arm swollen after 1st dose), FEELING HOT (Arm hot after 1st dose), PAIN IN EXTREMITY (Feet hurt after 1st dose/ Arm felt like bees biting after the 1st dose), MUSCULOSKELETAL STIFFNESS (Neck stiff after 1st dose), FEEDING DISORDER (Couldn't eat after 1st dose), NAUSEA (Nauseous after 1st dose), PYREXIA (Temperature of 101.4 F after 1st dose) and HEADACHE (Exploding headache after 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Not taking the 2nd dose), PRURITUS (Itchy after the 1st dose), TINNITUS (Ringing in ears after 1st dose), INFLUENZA (Felt like had the worst flu ever had after 1st dose), PERIPHERAL SWELLING (Arm swollen after 1st dose), FEELING HOT (Arm hot after 1st dose), PAIN IN EXTREMITY (Feet hurt after 1st dose/ Arm felt like bees biting after the 1st dose), MUSCULOSKELETAL STIFFNESS (Neck stiff after 1st dose), FEEDING DISORDER (Couldn't eat after 1st dose), NAUSEA (Nauseous after 1st dose), PYREXIA (Temperature of 101.4 F after 1st dose) and HEADACHE (Exploding headache after 1st dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2020, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, Body temperature: high (High) high and 101.4 (High) Temperature of 101.4 F after 1st dose.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment using  tylenol, gatorade,green tea was reported Concomitant medication information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: nni
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Nausea, Pain in extremity, Peripheral swelling, Product dose omission issue
Clinical narrative: Not taking the 2nd dose; Itchy after the 1st dose; Ringing in ears after 1st dose; Felt like had the worst flu ever had after 1st dose; Arm swollen after 1st dose; Arm hot after 1st dose; Feet hurt after 1st dose/ Arm felt like bees biting after the 1st dose; Neck stiff after 1st dose; Couldn't eat after 1st dose; Nauseous after 1st dose; Temperature of 101.4 F after 1st dose; Exploding headache after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Not taking the 2nd dose), PRURITUS (Itchy after the 1st dose), TINNITUS (Ringing in ears after 1st dose), INFLUENZA (Felt like had the worst flu ever had after 1st dose) and PERIPHERAL SWELLING (Arm swollen after 1st dose) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in August 2020, Nausea and Diarrhea.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Not taking the 2nd dose), PRURITUS (Itchy after the 1st dose), TINNITUS (Ringing in ears after 1st dose), INFLUENZA (Felt like had the worst flu ever had after 1st dose), PERIPHERAL SWELLING (Arm swollen after 1st dose), FEELING HOT (Arm hot after 1st dose), PAIN IN EXTREMITY (Feet hurt after 1st dose/ Arm felt like bees biting after the 1st dose), MUSCULOSKELETAL STIFFNESS (Neck stiff after 1st dose), FEEDING DISORDER (Couldn't eat after 1st dose), NAUSEA (Nauseous after 1st dose), PYREXIA (Temperature of 101.4 F after 1st dose) and HEADACHE (Exploding headache after 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Not taking the 2nd dose), PRURITUS (Itchy after the 1st dose), TINNITUS (Ringing in ears after 1st dose), INFLUENZA (Felt like had the worst flu ever had after 1st dose), PERIPHERAL SWELLING (Arm swollen after 1st dose), FEELING HOT (Arm hot after 1st dose), PAIN IN EXTREMITY (Feet hurt after 1st dose/ Arm felt like bees biting after the 1st dose), MUSCULOSKELETAL STIFFNESS (Neck stiff after 1st dose), FEEDING DISORDER (Couldn't eat after 1st dose), NAUSEA (Nauseous after 1st dose), PYREXIA (Temperature of 101.4 F after 1st dose) and HEADACHE (Exploding headache after 1st dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2020, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, Body temperature: high (High) high and 101.4 (High) Temperature of 101.4 F after 1st dose.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment using  tylenol, gatorade,green tea was reported Concomitant medication information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: nni